BlueCrest Capital Management’s LifePoint Health, Inc. LPNT Stock Holding History

BlueCrest Capital Management’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-23,225	Closed	-$1.5M	–	1759
2018 Q3	$1.5M	Buy	+23,225	New	+$1.42M	0.04%	329
2018 Q1	–	Sell	-8,273	Closed	-$412K	–	1736
2017 Q4	$412K	Sell	8,273 -3,344	-29%	-$166K	0.01%	561
2017 Q3	$673K	Buy	+11,617	New	+$691K	0.03%	446
2016 Q3	–	Sell	-6,128	Closed	-$401K	–	1133
2016 Q2	$401K	Sell	6,128 -1,294	-17%	-$88K	0.02%	602
2016 Q1	$514K	Buy	7,422 +3,269	+79%	+$218K	0.03%	498
2015 Q4	$305K	Sell	4,153 -2,825	-40%	-$201K	0.01%	733
2015 Q3	$495K	Sell	6,978 -2,935	-30%	-$238K	0.02%	595
2015 Q2	$862K	Buy	+9,913	New	+$749K	0.02%	531
2015 Q1	–	Sell	-7,000	Closed	-$503K	–	873
2014 Q4	$503K	Buy	+7,000	New	+$485K	0.02%	447

Other funds holding LPNT

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

BlueCrest Capital Management's LPNT Position: Q4 2018 in Review

BlueCrest Capital Management sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 23,225 shares — an estimated $1.5M sold.

BlueCrest Capital Management first reported a position in LPNT in Q4 2014 and held it in 9 quarters. The position peaked at $1.5M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.

BlueCrest Capital Management reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
BlueCrest Capital Management sold 23,225 LifePoint Health, Inc. shares in Q4 2018, an estimated $1.5M.
BlueCrest Capital Management first reported a position in LifePoint Health, Inc. in Q4 2014 and held it in 9 quarters.
BlueCrest Capital Management's LifePoint Health, Inc. position peaked at $1.5M in Q3 2018.
3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.